We are live on
!
Find out more
ROTUOC
Regents of the University of California Portfolio holdings
AUM
$4.36B
1-Year Est. Return
33.89%
This Fund
S&P 500
This Quarter
Est. Return
+2.23%
1 Year Est. Return
+33.89%
3 Year Est. Return
+86.09%
5 Year Est. Return
+63.96%
10 Year Est. Return
+870.04%
AUM
$849M
AUM Growth
+$65.8M
(+8.4%)
Cap. Flow
+$69.9M
Cap. Flow
% of AUM
8.22%
Top 10 Holdings %
Top 10 Hldgs %
94.73%
Holding
40
New
6
Increased
3
Reduced
6
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IS
ironSource Ltd.
IS
|
+$79.3M |
| 2 |
Alibaba
BABA
|
+$28.5M |
| 3 |
Sana Biotechnology
SANA
|
+$8.14M |
| 4 |
Arvinas
ARVN
|
+$6.83M |
| 5 |
Pinduoduo
PDD
|
+$3.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
+$21M |
| 2 |
Blue Owl Capital
OBDC
|
+$16.1M |
| 3 |
Upstart Holdings
UPST
|
+$13.9M |
| 4 |
RAPT
RAPT Therapeutics
RAPT
|
+$5.75M |
| 5 |
Snowflake
SNOW
|
+$2.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 66.75% |
| 2 | Technology | 10.42% |
| 3 | Consumer Discretionary | 8.87% |
| 4 | Healthcare | 8.25% |
| 5 | Real Estate | 2.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Blue Owl Capital
OBDC
$5.75B
| $529M | 62.34% |
37,495,893
-1,113,858
| -3% | -$16.1M |
|
|
IS
2
DELISTED
ironSource Ltd.
IS
| $87M | 10.24% |
+8,000,000
| New | +$79.3M |
|
|
3
Alibaba
BABA
$300B
| $68.5M | 8.06% |
462,431
+156,400
| +51% | +$28.5M |
|
4
Opendoor
OPEN
$3.39B
| $25.2M | 2.96% |
1,266,723
+37,541
| +3% | +$607K |
|
|
5
Upstart Holdings
UPST
$2.83B
| $24.8M | 2.92% |
78,438
-70,593
| -47% | -$13.9M |
|
|
RAPT
6
DELISTED
RAPT Therapeutics
RAPT
| $18.9M | 2.23% |
76,083
-21,741
| -22% | -$5.75M |
|
7
Nurix Therapeutics
NRIX
$2.76B
| $17.1M | 2.02% |
571,212
| – | – |
|
8
Intellia Therapeutics
NTLA
$1.69B
| $14.9M | 1.76% |
111,440
| – | – |
|
9
Estee Lauder
EL
$31.7B
| $10M | 1.18% |
33,400
| – | – |
|
|
10
Sana Biotechnology
SANA
$1.13B
| $8.73M | 1.03% |
+387,508
| New | +$8.14M |
|
|
11
Arvinas
ARVN
$580M
| $6.35M | 0.75% |
+77,302
| New | +$6.83M |
|
12
Affirm
AFRM
$24.6B
| $6.29M | 0.74% |
52,842
-5,520
| -9% | -$441K |
|
|
13
Pinduoduo
PDD
$127B
| $4.59M | 0.54% |
50,582
+37,102
| +275% | +$3.61M |
|
14
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
| $2.69M | 0.32% |
5,600
| – | – |
|
15
Air Products & Chemicals
APD
$67.7B
| $2.61M | 0.31% |
10,200
| – | – |
|
16
S&P Global
SPGI
$121B
| $2.55M | 0.3% |
6,000
| – | – |
|
17
DoorDash
DASH
$92.1B
| $2.28M | 0.27% |
+11,089
| New | +$2.12M |
|
18
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.19M | 0.26% |
8,043
| – | – |
|
19
ExxonMobil
XOM
$657B
| $1.98M | 0.23% |
33,600
| – | – |
|
20
Merck
MRK
$328B
| $1.62M | 0.19% |
21,600
| – | – |
|
21
Texas Instruments
TXN
$253B
| $1.25M | 0.15% |
6,500
| – | – |
|
22
Pfizer
PFE
$150B
| $1.19M | 0.14% |
27,645
| – | – |
|
23
Walt Disney
DIS
$178B
| $1.01M | 0.12% |
6,000
| – | – |
|
|
ONEM
24
DELISTED
1Life Healthcare
ONEM
| $989K | 0.12% |
+48,861
| New | +$1.26M |
|
25
Verizon
VZ
$195B
| $958K | 0.11% |
17,735
| – | – |
|
Similar funds
SFM
EC
EQF
NEI
FIS
CAU
IUHSA
CW
Regents of the University of California's Q3 2021 Portfolio in Review
As of Q3 2021, Regents of the University of California held 40 positions worth $849M, up 8.4% from $784M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Regents of the University of California deployed $69.9M of net new capital in Q3 2021, opening 6 new positions and adding to 3 existing holdings. Its largest new stake was ironSource Ltd.: 8,000,000 shares worth $87M.
By sector, the portfolio is most concentrated in Financials at 67% of assets, down from 74% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Blue Owl Capital, an estimated $16.1M trimmed.
- Regents of the University of California's largest Q3 2021 buy was ironSource Ltd.: 8,000,000 shares worth $87M.
- Regents of the University of California added most to Alibaba in Q3 2021, an estimated $28.5M increase.
- Regents of the University of California's biggest Q3 2021 reduction was Blue Owl Capital, cutting an estimated $16.1M.
- Regents of the University of California fully exited Constellation Pharmaceuticals, Inc. in Q3 2021, selling an estimated $21M.
- Regents of the University of California's ten largest holdings make up 95% of its $849M portfolio in Q3 2021.
- Regents of the University of California opened 6 new positions and closed 3 in Q3 2021.
- Regents of the University of California's portfolio value rose 8.4% quarter-over-quarter to $849M.
Based on Regents of the University of California's 13F filing for Q3 2021, filed 20 Oct 2021.